Search results for "Menopausa"

showing 10 items of 119 documents

Sinergia d'azione tra il trattamento farmacologico e riabilitativo nell'osteoporosi post-menopausale

2013

L'osteoporosi è un disordine scheletrico caratterizzato da compromissione della resistenza dell'osso che predispone ad un aumentato rischio di fratture. Presso l'U.O.C. di Riabilitazione dell'A.O.U.P. Paolo Giaccone tra gennaio 2009 e marzo 2013, sono state sottoposte a trattamento farmacologico associata alla somministrazione giornaliera di calcio e vitamina D, 149 donne in età post-menopausale, suddivise in 2 gruppi: il gruppo A è stato sottoposto solamente a terapia farmacologica, il gruppo B ha eseguito, in associazione al trattamento farmacologico, un progetto-programma riabilitativo. Lo studio ha messo in evidenza l'efficacia antifratturativa dei farmaci utilizzati nel trattamento del…

Settore MED/34 - Medicina Fisica E Riabilitativariabilitazione osteoporosi calcio vitamina D menopausa
researchProduct

Management of urinary incontinence in postmenopausal women: An EMAS clinical guide.

2020

INTRODUCTION: The prevalence of urinary incontinence and of other lower urinary tract symptoms increases after the menopause and affects between 38 % and 55 % of women aged over 60 years. While urinary incontinence has a profound impact on quality of life, few affected women seek care. AIM: The aim of this clinical guide is to provide an evidence-based approach to the management of urinary incontinence in postmenopausal women. MATERIALS AND METHODS: Literature review and consensus of expert opinion. SUMMARY RECOMMENDATIONS: Healthcare professionals should consider urinary incontinence a clinical priority and develop appropriate diagnostic skills. They should be able to identify and manage a…

Stress incontinencemedicine.medical_specialtyAgingUrinary incontinenceUrinary incontinenceGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineQuality of lifeLower urinary tract symptomsmedicineHumans030212 general & internal medicineMidurethral SlingsAging; Estrogens; Menopause; Midurethral slings; Urinary incontinence030219 obstetrics & reproductive medicinePostmenopausal womenbusiness.industryObstetrics and GynecologyEstrogensmedicine.diseasePostmenopauseMenopauseUrinary IncontinenceSacral nerve stimulationPhysical therapyFemaleMidurethral slingsmedicine.symptomMenopausebusiness
researchProduct

Comment on "Effects of Elastic Resistance Band Exercise on Postural Balance, Estrogen, Bone Metabolism Index, and Muscle Strength of Perimenopausal P…

2017

bonesmedicine.medical_specialtymedicine.drug_class030209 endocrinology & metabolismBone remodeling03 medical and health sciences0302 clinical medicineInternal medicineestrogenmedicinePostural BalanceHumans030212 general & internal medicineMuscle StrengthExercisePostural Balancebusiness.industryta3141Estrogensta3142perimenopausal womenPerimenopauseEndocrinologyEstrogenMuscle strengthFemaleGeriatrics and Gerontologybone mineral densitybusinessJournal of the American Geriatrics Society
researchProduct

The Impact of Hormone Therapy on Health

2017

Hormone therapy (HT) has menopausal symptom control as the main indication. However, and because estrogens have receptors spread over many systems in the body, the use of hormones may have consequences on health. Hormone therapy consists of estrogens essentially, since menopausal symptoms mainly derive from estrogen deprivation at different target tissues. However, the normal ovarian cycle includes the regular secretion of progesterone during the days of the luteal phase. Progesterone has a neutralizing effect over endometrial proliferation, this being the reason for adding progestogens to HT formulations in order to protect endometrium. So, guidelines recommend that women with uterus use e…

business.industrymedicine.drug_classmedicine.medical_treatmentUterusPhysiologyLuteal phaseEndometriummedicine.anatomical_structuremedicineMenopausal SymptomHormone therapyReceptorbusinessProgestinhormones hormone substitutes and hormone antagonistsHormone
researchProduct

Efecto de las ciclooxigenasas en la biodisponibilidad del óxido nítrico en la respuesta vascular al tromboxano A2 en un modelo murino de envejecimien…

2018

El envejecimiento y la pérdida de los estrógenos durante la menopausia se asocian a una menor biodisponibilidad del NO, un aumento de los niveles de O2- vascular y un incremento de sustancias contráctiles, entre ellas el TXA2. Queda por determinar si los efectos deletéreos vasculares inducidos por el TXA2 durante el envejecimiento median una disminución en la biodisponibilidad de NO y un aumento en la producción de O2- y si están modulados por estrógenos. Para ello, se validó un modelo de envejecimiento vascular en ratonas con senescencia acelerada (SAM), con ratonas de la cepa SAMP8 con predisposición a la senescencia acelerada y ratonas SAMR1, con resistencia al desarrollo de senescencia …

ciclooxigenasaUNESCO::CIENCIAS MÉDICAS ::Farmacodinámica::Mecanismos de acción de los medicamentosUNESCO::CIENCIAS DE LA VIDA::Biología molecularanió superòxiddisfunció endotelialmenopausaenvellimentsamp8:CIENCIAS DE LA VIDA::Biología molecular [UNESCO]:CIENCIAS DE LA VIDA::Fisiología humana ::Fisiología cardiovascular [UNESCO]UNESCO::CIENCIAS DE LA VIDA::Fisiología humana ::Fisiología cardiovascularòxid nítricestrògens:CIENCIAS MÉDICAS ::Farmacodinámica::Mecanismos de acción de los medicamentos [UNESCO]
researchProduct

Biosilica-Based Strategies for Treatment of Osteoporosis and Other Bone Diseases

2011

Osteoporosis is a common disease in later life, which has become a growing public health problem. This degenerative bone disease primarily affects postmenopausal women, but also men may suffer from reduced bone mineral density. The development of prophylactic treatments and medications of osteoporosis has become an urgent issue due to the increasing proportion of the elderly in the population. Apart from medical/hormonal treatments, current strategies for prophylaxis of osteoporosis are primarily based on calcium supplementation as a main constituent of bone hydroxyapatite mineral. Despite previous reports suggesting an essential role in skeletal growth and development, the significance of …

education.field_of_studyPostmenopausal womenBone densityBone diseaseDietary SiliconOsteoporosisPopulationBiologymedicine.diseaseBioinformaticsOsteoprotegerinStrontium ranelatemedicineeducationmedicine.drug
researchProduct

Serum inhibin A, inhibin B, pro-alphaC, and activin A levels in women with idiopathic premature ovarian failure.

2003

Serum inhibin A, inhibin B, pro-alphaC, and activin A levels in 30 women with idiopathic premature ovarian failure (POF), 30 postmenopausal women, and 30 age-matched fertile women were determined. Women with POF showed low levels of inhibin A and inhibin B, but not of activin A, whereas the levels of pro-alphaC were significantly higher than in postmenopausal women. Thus, the circulating level of pro-alphaC could be a marker for assessing residual ovarian function in women with POF.

endocrine systemInhibin amedicine.medical_specialtyendocrine system diseasesPrimary Ovarian InsufficiencyAndrologyOvarian functionInternal medicineMedicineHumansInhibinsProtein Precursorsreproductive and urinary physiologyInhibin bPostmenopausal womenbusiness.industryObstetrics and Gynecologyfemale genital diseases and pregnancy complicationsActivin aPostmenopauseIdiopathic premature ovarian failureEndocrinologyReproductive MedicineFemalebusinesshormones hormone substitutes and hormone antagonistsFertility and sterility
researchProduct

Effects of combined hormone replacement therapy or its effective agents on the IGF-1 pathway in skeletal muscle.

2010

Objectives To investigate the effects of combined hormone replacement therapy (HRT) and its effective agents on the IGF-1 signaling pathway. Design and methods To examine the effects of HRT on skeletal muscle in vivo, we utilized pre- and post-intervention samples from a randomized double blinded trial with 50–57-year-old women. The intervention included the year-long use of either HRT preparation (2 mg 17β-estradiol, E2; 1 mg norethisterone acetate, NETA, n = 10) or placebo (CO, n = 9). Microarray technology and quantitative PCR (qPCR) were used to study the expression of insulin-like growth factor I (IGF-1) and its splice variants as well as IGF-1 receptor, Akt1, mTOR, FOXO1, FOXO3, atrog…

estradioliTranscription GeneticEndocrinology Diabetes and MetabolismMuscle Fibers SkeletalEstrogen receptorpostmenopausal womenMuscle ProteinsFOXO1Receptor IGF Type 10302 clinical medicineEndocrinologyProtein IsoformsTestosteroneInsulin-Like Growth Factor IReceptorRandomized Controlled Trials as Topic0303 health sciencesEstradiolMyogenesisForkhead Box Protein O1TOR Serine-Threonine KinasesEstrogen Replacement TherapyForkhead Box Protein O3Forkhead Transcription FactorsMiddle Agedmedicine.anatomical_structureReceptors EstrogenReceptors AndrogenFemalemedicine.medical_specialtynorethisterone acetate030209 endocrinology & metabolismBiologypostmenopausaalinen nainen03 medical and health sciencesInternal medicinemedicineHumansnoretisteroniasetaattiluurankolihasskeletal muscleMuscle SkeletalProtein kinase BPI3K/AKT/mTOR pathway030304 developmental biologyhormonikorvaushoitoSKP Cullin F-Box Protein LigasesSkeletal muscleAndrogen receptorNorethindrone AcetateEndocrinologyHormone replacement therapyIGF-1 signalointiNorethindroneIGF-1 signalingProto-Oncogene Proteins c-aktGrowth hormoneIGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
researchProduct

Muscle function in monozygotic female twin pairs discordant for hormone replacement therapy

2011

Introduction: Postmenopausal monozygotic twin pairs discordant for hormone replacement therapy (HRT) provide an advantageous study design controlling for genetic background for elucidating the relationships between aging, sex hormone levels, muscle strength, contractile capacity, and fatigability. Methods: Thirteen postmenopausal monozygotic twin pairs discordant for HRT were measured for maximal voluntary torque (MVC) and twitch characteristics using electrical stimulation before and after intermittent dynamic plantarflexor exercise until exhaustion. Results: Peak twitch torque was 32% higher in HRT users than in their non-HRT, genetically identical sisters (P = 0.002), but MVC did not dif…

estradiolimedicine.medical_specialtygenetic structuresPhysiology030310 physiologyMonozygotic twinStimulationplantarflexor03 medical and health sciencesCellular and Molecular NeuroscienceMuscle nerveSex hormone-binding globulinPhysiology (medical)Internal medicinemedicineHumansvoimaMuscle StrengthtwitchMuscle Skeletalväsyminen030304 developmental biology0303 health sciencesPostmenopausal womenbiologyEstradiolbusiness.industryElectromyographyEstrogen Replacement TherapySkeletal muscleTwins MonozygoticMiddle AgedestrogeeniEndocrinologymedicine.anatomical_structureTransgender hormone therapyMuscle Fatiguebiology.proteinTime to peakfatigueFemalesense organsNeurology (clinical)strengthbusinesshuman activitiesMuscle ContractionMuscle & Nerve
researchProduct

Design and protocol of Estrogenic Regulation of Muscle Apoptosis (ERMA) study with 47 to 55-year-old women's cohort : novel results show menopause-re…

2018

Objective: The multidisciplinary Estrogenic Regulation of Muscle Apoptosis (ERMA) study was designed to reveal how hormonal differences over the menopausal stages affect the physiological and psychological functioning of middle-aged women. This paper describes the protocol and nonrespondent analysis of ERMA and novel findings on menopausal differences in blood count variables and their association with female sex hormones. Methods: Women aged 47 to 55 years were assigned to pre, early peri, late peri, and postmenopausal groups based on follicle-stimulating hormone (FSH) and bleeding diary. Multivariate linear regression models were constructed to estimate the association of 17b-estradiol (E…

estrogeenit17b-Estradiolestradioliohjelmoitunut solukuolemavalkosolutvaihdevuodetneutrophil-to-lymphocyte ratioFSHblood viscosityleucocyte countlihaskuntomenopausal status
researchProduct